DPM-1001
CAS: 1471172-27-6
Rif. 3D-WIC17227
| 5mg | Prezzo su richiesta | ||
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Informazioni sul prodotto
DPM-1001 is a novel, orally available tyrosine phosphatase inhibitor. DPM-1001 prevents the activation of protein phosphatases by inhibiting the enzyme responsible for removing phosphate groups from tyrosine residues. This leads to an accumulation of insulin receptor substrate 1 (IRS1) in cells, which is associated with type 2 diabetes and other metabolic diseases. In addition, DPM-1001 has been shown to inhibit cancer growth in vitro and in vivo, as well as to prevent neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. The chemical structure of DPM-1001 is apigenin linked through a phosphate group to a quinoline moiety. The symptoms of DPM-1001 overdose are nausea, vomiting, diarrhea, abdominal pain, dizziness and headache.
Proprietà chimiche
Richiesta tecnica su: 3D-WIC17227 DPM-1001
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
